1-6 of 6
Lori S. Muffly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Clinical Trials & Observations
Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand, Noam E. Kopmar, Chenyu Lin, Anjali S. Advani, Simone E. Dekker, Vishal K. Gupta, Timothy E. O'Connor, Nikeshan Jeyakumar, Ibrahim N. Muhsen, Yannis Valtis, Amy Zhang, Katharine Miller, Katherine Sutherland, Kaitlyn C. Dykes, Mohamed Ahmed, Evan Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M. O'Dwyer, LaQuisa C. Hill, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T. Leonard, Noelle V. Frey, Jae H. Park, Marlise R. Luskin, Veronika Bachanova, Ahmed Galal, Michael R. Bishop, Wendy Stock, Ryan D. Cassaday, Vinod Pullarkat, Bijal D. Shah, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6139–6147.
https://doi.org/10.1182/bloodadvances.2024013747
Published: 2024
Includes: Supplemental data
Journal Articles

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Clinical Trials & Observations
Cameron S. Bader, Anna Pavlova, Robert Lowsky, Lori S. Muffly, Parveen Shiraz, Sally Arai, Laura J. Johnston, Andrew R. Rezvani, Wen-Kai Weng, David B. Miklos, Matthew J. Frank, John S. Tamaresis, Vaibhav Agrawal, Sushma Bharadwaj, Surbhi Sidana, Judith A. Shizuru, Nathaniel B. Fernhoff, Amy Putnam, Scott Killian, Bryan J. Xie, Robert S. Negrin, Everett H. Meyer
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1105–1115.
https://doi.org/10.1182/bloodadvances.2023011625
Published: 2024
Includes: Supplemental data
Journal Articles

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

Clinical Trials & Observations
Catherine J. Lee, Soyoung Kim, Heather R. Tecca, Stephanie Bo-Subait, Rachel Phelan, Ruta Brazauskas, David Buchbinder, Betty K. Hamilton, Minoo Battiwalla, Navneet S. Majhail, Hillard M. Lazarus, Peter J. Shaw, David I. Marks, Mark R. Litzow, Saurabh Chhabra, Yoshihiro Inamoto, Zachariah DeFilipp, Gerhard C. Hildebrandt, Richard F. Olsson, Kimberly A. Kasow, Jane L. Liesveld, Seth J. Rotz, Sherif M. Badawy, Neel S. Bhatt, Jean A. Yared, Kristin M. Page, Martha L. Arellano, Michael Kent, Nosha Farhadfar, Sachiko Seo, Peiman Hematti, César O. Freytes, Alicia Rovó, Siddhartha Ganguly, Sunita Nathan, Linda Burns, Bronwen E. Shaw, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2020) 4 (6): 983–992.
https://doi.org/10.1182/bloodadvances.2019001126
Published: 2020
Includes: Supplemental data
Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Clinical Trials & Observations
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2454–2464.
https://doi.org/10.1182/bloodadvances.2019000297
Published: 2019
Includes: Supplemental data
Journal Articles

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation

Clinical Trials & Observations
Michael A. Spinner, Ranjana H. Advani, Richard T. Hoppe, Robert Lowsky, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1547–1550.
https://doi.org/10.1182/bloodadvances.2018021071
Published: 2018
Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Clinical Trials & Observations
Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1347–1357.
https://doi.org/10.1182/bloodadvances.2017007716
Published: 2017
Includes: Supplemental data